1. Home
  2. BNGO vs ADIL Comparison

BNGO vs ADIL Comparison

Compare BNGO & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.15

Market Cap

12.5M

Sector

Industrials

ML Signal

HOLD

Logo Adial Pharmaceuticals Inc

ADIL

Adial Pharmaceuticals Inc

HOLD

Current Price

$3.73

Market Cap

10.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNGO
ADIL
Founded
2003
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.5M
10.2M
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
BNGO
ADIL
Price
$1.15
$3.73
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
$5.00
★ $8.33
AVG Volume (30 Days)
★ 271.9K
31.7K
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 94.50
N/A
EPS
★ N/A
N/A
Revenue
★ $12,000,735.00
N/A
Revenue This Year
$12.73
N/A
Revenue Next Year
$34.74
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 26.26
N/A
52 Week Low
$1.00
$0.13
52 Week High
$2.23
$9.53

Technical Indicators

Market Signals
Indicator
BNGO
ADIL
Relative Strength Index (RSI) 32.20 44.36
Support Level $1.10 $2.38
Resistance Level $1.19 $4.94
Average True Range (ATR) 0.08 0.35
MACD -0.03 0.08
Stochastic Oscillator 13.75 51.42

Price Performance

Historical Comparison
BNGO
ADIL

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.

Share on Social Networks: